CTT MU Participated in Prague.bio Conference 2025
On Thursday, September 25, the third edition of the Prague.bio Conference 2025 took place in Prague, bringing together over 400 participants from around the world.
Promising research on cancer treatment was presented in Munich
The technology of casein kinase 1 inhibitors from MUNI laboratories was presented by TTO on May 8 and 9 at the BioVaria conference in Munich. Potential investors could learn more about the promising research that could help fight leukemia and other types of cancer. TTO is seeking for partners who will help to move this interesting project a step further. At the conference, the technology was presented in the form of a poster on a stand with the Prague IOCBTech by our business manager Jana Daňková.
